9/15/2009

The FDA accepted an abbreviated new-drug application for injectable glatiramer acetate, Mylan and Natco Pharma's multiple sclerosis drug candidate. The product is a generic version of Teva Pharmaceutical Industries' blockbuster drug Copaxone.

Full Story:
Bloomberg

Related Summaries